A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage

• Subject with compatible symptoms with an acute coronary syndrome, for at least 15 minutes and not older than 3 hours (eg discomfort, tightness or chest pain, pain radiating to the left arm or two arms, pain in the jaw, pain in the back / neck / stomach, breathlessness , cold sweats, nausea / vomiting , dizziness )
• Man or woman,
• Patient Did not receive heparin or low molecular weight heparin (LMWH ) before the initial blood sample ,
• Patient Agreeing to participate in the study and who signed an informed consent

Exclusion Criteria:

• Minor or major patient trust
• Patient Not having signed informed consent (refusal , physical or mental disability ... )
• Patient Who received anticoagulation before carrying blood samples
• Patient With a progressive septic processes , neoplasia undergoing treatment, dialyzed kidney failure, a history of surgery or coronary angioplasty less than six months.
• Transplanted heart, renal or hepatic
• heart attack
• Subject Whose symptoms clearly eliminates acute coronary syndrome ( penetrating trauma, traumatic injury by crushing ... )
• Patient Died between the time of inclusion and arrival in the cardiology intensive care ( SIC )
• Patient Withdrawing consent under study